Impact of vaccination on the epidemiology and prognosis of pneumonia
Rev. esp. quimioter
; 35(supl. 1): 104-110, abr. - mayo 2022. ilus, tab, graf
Artigo
em Inglês
| IBECS
| ID: ibc-205358
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Adults with lung diseases, comorbidities, smokers, andelderly are at risk of lung infections and their consequences.Community-acquired pneumonia happen in more than 1% ofpeople each year. Possible pathogens of community-acquiredpneumonia include viruses, pneumococcus and atypicals. TheCDC recommend vaccination throughout life to provide immunity, but vaccination rates in adults are poor.Tetravalent and trivalent influenza vaccine is designed annually during the previous summer for the next season. Theavailable vaccines include inactivated, adjuvant, double dose,and attenuated vaccines. Their efficacy depends on the variantof viruses effectively responsible for the outbreak each year,and other reasons.Regarding the pneumococcal vaccine, there coexist theold polysaccharide 23-valent vaccine with the new conjugate10-valent and 13-valent conjugate vaccines. Conjugate vaccinesdemonstrate their usefulness to reduce the incidence of pneumococcal pneumonia due to the serotypes present in the vaccine.Whooping cough is still present, with high morbidity andmortality rates in young infants. Adults pertussis vaccine isavailable, it could contribute to the control of whooping coughin the most susceptible, but it is not present yet in the calendarof adults around the world.About 10 vaccines against SARS-CoV-2 have been developedin a short time, requiring emergency use authorization. A highrate of vaccination was observed in most of the countries. Boosterdoses became frequent after the loss of effectiveness against newvariants. The future of this vaccine is yet to be written. (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Pneumonia
/
Vacinação em Massa
/
Infecções por Coronavirus
/
Pandemias
Limite:
Adulto
/
Idoso
/
Humanos
Idioma:
Inglês
Revista:
Rev. esp. quimioter
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital de Clínicas/Argentina